MacroGenics
MGNX
#8706
Rank
โ‚น22.37 B
Marketcap
โ‚น351.99
Share price
-2.38%
Change (1 day)
155.35%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -โ‚น134.65

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น145.95. In 2025 the company made an earnings per share (EPS) of -โ‚น112.56 a decrease over its 2024 EPS that were of -โ‚น102.07.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น134.6519.62%
2025-โ‚น112.5610.28%
2024-โ‚น102.07613.33%
2023-โ‚น14.31-92.31%
2022-โ‚น186.01-42.14%
2021-โ‚น321.4636.44%
2020-โ‚น235.61-21.84%
2019-โ‚น301.43-24.58%
2018-โ‚น399.68675.93%
2017-โ‚น51.51-68.05%
2016-โ‚น161.21168.25%
2015-โ‚น60.10-55%
2014-โ‚น133.553400%
2013-โ‚น3.82-108.68%
2012โ‚น43.9724.49%
2011โ‚น35.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.96-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,692-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,381-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น707.79-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น341.01-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น339.59-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น218.44 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA